Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Clin Belg ; 77(1): 51-58, 2022 Feb.
Article in English | MEDLINE | ID: mdl-32623970

ABSTRACT

BACKGROUND: Malignant cardiac tamponade is a life-threatening condition that requires prompt treatment and effective management to prevent recurrence. This paper describes safety and efficacy outcomes after intrapericardial instillation of bleomycin as well as possible predictors of survival. METHODS: We performed a 10-year retrospective, single-center study to evaluate the safety and efficacy of intrapericardial instillation of bleomycin in patients with suspected malignant cardiac tamponade. RESULTS: Intrapericardial instillation of bleomycin was performed in 31 cancer patients (9 men, 22 women) presenting with cardiac tamponade. Non-fatal complications occurred in 3 patients and relapse occurred in 1 patient. Overall survival was less than 10% at the end of the study. Median survival was 104 days (95% CI, 0-251 days). Survival was compared between different groups (defined by primary tumor, type of tumor, TNM stage and results of cytological analysis) with median survival being considerably higher when oncologic therapy was altered afterwards. CONCLUSIONS: The use of intrapericardial bleomycin instillation following pericardiocentesis for malignant cardiac tamponade is a safe procedure with a high success rate. Survival rates depend on further oncological treatment options available.


Subject(s)
Antineoplastic Agents , Cardiac Tamponade , Lung Neoplasms , Pericardial Effusion , Antineoplastic Agents/therapeutic use , Bleomycin/adverse effects , Cardiac Tamponade/drug therapy , Female , Humans , Lung Neoplasms/drug therapy , Male , Neoplasm Recurrence, Local , Retrospective Studies
2.
Acta Clin Belg ; 77(1): 153-156, 2022 Feb.
Article in English | MEDLINE | ID: mdl-32684115

ABSTRACT

In this article, we report a patient with new-onset dyspnea and symptoms suggestive of heart failure, who had an unexpected diagnosis of a large left atrial myxoma with diastolic protrusion into the left ventricle. We further underline the role of cardiac Point-of-Care Ultrasound (POCUS) in the initial evaluation of patients with cardiac complaints in the emergency room setting. It can help to differentiate the patients' symptoms in order to achieve a more accurate diagnosis and thus increase the efficacy of the established therapy. In some cases, as with this patient, it can help to establish a diagnosis which needs prompt therapy.


Subject(s)
Echocardiography , Point-of-Care Systems , Dyspnea/diagnostic imaging , Dyspnea/etiology , Emergency Service, Hospital , Humans , Point-of-Care Testing , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...